Corrigendum to 'The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever' [Neuromuscular Disorders 32 (2022) 575-577].

Neuromuscul Disord

Department of Pediatrics, Yeditepe School of Medicine, Istanbul, Turkey. Electronic address:

Published: October 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.nmd.2022.09.004	DOI Listing

Publication Analysis

corrigendum 'the

'the outcome

outcome sma

sma cases

cases treated

treated nusinersen

nusinersen hours

hours three

three days

days life

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!